# Rubia cordifolia L. Dichloromethane Extract Ameliorates Contrast-Induced Acute Kidney Injury by Activating Autophagy via the LC3B/p62 Axis

**Authors:** Xiaoying Sun, Kangxu He, Guanzhong Chen, Xiaoda Yang, Xinhui Pan, Kai Liao

PMC · DOI: 10.3390/molecules31020316 · 2026-01-16

## TL;DR

This study shows that an extract from Rubia cordifolia L. protects against kidney injury caused by contrast agents, possibly by boosting autophagy.

## Contribution

The study identifies Rubia cordifolia L. dichloromethane extract as a potential therapeutic for contrast-induced acute kidney injury via autophagy activation.

## Key findings

- RCDE high-dose group significantly reduced serum SCr and BUN levels in CIAKI rats.
- RCDE attenuated renal histopathological damage and modulated oxidative stress markers.
- RCDE modulated autophagy-related proteins, including downregulating p62 and the LC3B-II/LC3B-I ratio.

## Abstract

Contrast-induced acute kidney injury (CIAKI) has emerged as the third most prevalent etiology of clinically acquired acute kidney injury, with a lack of specific preventive and therapeutic strategies. Rubia Cordifolia L. (madder root), a medicinal herb with a long-standing history and extensive clinical application, exhibits multiple pharmacological activities. This study aimed to clarify the renal protective effect of Rubia cordifolia L. dichloromethane extract (RCDE) on CIAKI modeling rats and investigate potential anti-apoptotic and autophagy-inducing effects molecular mechanisms. In this study, RCDE constituents were identified by UPLC-Q-TOF-MS. A CIAKI rat model was established to evaluate the nephroprotective effect of RCDE. The results showed that RCDE high-dose group significantly decreased serum SCr and BUN levels, attenuated renal histopathological damage, and modulated oxidative stress markers by decreasing MDA and CAT while increasing SOD, compared with the model group. It downregulated the expressions of Bcl-2, caspase-3 and p62, upregulated the expressions of Bax, Beclin1 and reduced the LC3B-II/LC3B-I ratio in renal tissues. Molecular docking indicates that anthraquinone compounds are probably the principal active constituents of RCDE. This study provides experimental evidence for the intervention efficacy of RCDE against CIAKI.

## Linked entities

- **Genes:** BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], Casp3 (caspase 3) [NCBI Gene 12367], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], BECN1 (beclin 1) [NCBI Gene 8678], MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631]
- **Chemicals:** dichloromethane (PubChem CID 6344), BUN (PubChem CID 91971254), MDA (PubChem CID 1614)
- **Diseases:** acute kidney injury (MONDO:0002492)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Becn1 (beclin 1) [NCBI Gene 114558] {aka Beclin1}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Khdrbs1 (KH RNA binding domain containing, signal transduction associated 1) [NCBI Gene 117268] {aka P62, Sam68}, Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}
- **Diseases:** renal histopathological damage (MESH:D007674), CIAKI (MESH:D058186)
- **Chemicals:** anthraquinone (MESH:D000880), MDA (MESH:D015104), RCDE (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Rubia cordifolia (species) [taxon 339321]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12844358/full.md

---
Source: https://tomesphere.com/paper/PMC12844358